Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)

ClinicalTrials.gov ID: NCT02580591

Public ClinicalTrials.gov record NCT02580591. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 3:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomised, Double Blind, Placebo-controlled, Parallel Group, Efficacy, Safety and Tolerability Trial of Once Daily, Oral Doses of Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-3)

Study identification

NCT ID
NCT02580591
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
977 participants

Conditions and interventions

Interventions

  • Empagliflozin Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 21, 2015
Primary completion
Sep 11, 2017
Completion
Sep 19, 2017
Last update posted
Nov 1, 2018

2015 – 2017

United States locations

U.S. sites
39
U.S. states
18
U.S. cities
36
Facility City State ZIP Site status
Healthscan Clinical Trials LLC Montgomery Alabama 36106
John Muir Physician Network Clinical Research Center Concord California 94520
Valley Research Fresno California 93720
Marin Endocrine Care and Research Greenbrae California 94904
Pacific Research Partners, LLC Oakland California 94607
NorCal Endocrinology and Internal Medicine San Ramon California 94583
William Sansum Diabetes Center Santa Barbara California 93105
University of Colorado Denver Aurora Colorado 80045
International Research Associates, LLC Hialeah Florida 33012
Solutions Through Advanced Research, Inc. Jacksonville Florida 32225
University of Miami Miami Florida 33136
Suncoast Clinical Research, Inc. New Port Richey Florida 34652
Atlanta Diabetes Associates Atlanta Georgia 30318
Physicians Research Associates, LLC Lawrenceville Georgia 30046
Sestron Clinical Research Marietta Georgia 30060
Eagle's Landing Diabetes and Endocrinology Stockbridge Georgia 30281
Northwest Endo Diabetes Research, LLC Arlington Heights Illinois 60005
Kentucky Diabetes Endocrinology Center Lexington Kentucky 40503
University of Maryland School of Medicine Baltimore Maryland 21201
MODEL Clinical Research Baltimore Maryland 21204
Clinical Research Consultants, LLC Kansas City Missouri 64111
Desert Endocrinology Clinical Research Center Henderson Nevada 89052
Palm Research Center Las Vegas Nevada 89128
Endocrine-Diabetes Care and Resource Center Rochester New York 14607
Endocrine Associates of Long Island, PC Smithtown New York 11787
Diabetes Endocrinology Research Center of Western New York Williamsville New York 14221
Diabetes and Endocrinology Consultants, PC Morehead City North Carolina 28557
Holzer Clinic LLC Gallipolis Ohio 45631
COR Clinical Research, LLC Oklahoma City Oklahoma 73103
Strand Physician Specialists dba Carolina Health Specialists Myrtle Beach South Carolina 29572
AM Diabetes and Endocrinology Center Bartlett Tennessee 38133
Holston Medical Group Bristol Tennessee 37620
University Diabetes and Endocrine Consultants Chattanooga Tennessee 37411
Texas Diabetes & Endocrinology PA Austin Texas 78749
Texas Health Physicians Group Dallas Texas 75218
Dallas Diabetes and Endocrine Center Dallas Texas 75230
Research Institute of Dallas Dallas Texas 75231
Endeavor Clinical Trials, PA San Antonio Texas 78229
Virginia Endocrinology Research Chesapeake Virginia 23321

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 150 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02580591, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2018 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02580591 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →